163 related articles for article (PubMed ID: 32421366)
1. A systematic review and meta-analysis of higher expression of folate receptor alpha (FOLR1) predicts poor cancer prognosis.
Liu Y; Lian T; Yao Y
Biomarkers; 2020 Jul; 25(5):367-374. PubMed ID: 32421366
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
Köbel M; Madore J; Ramus SJ; Clarke BA; Pharoah PD; Deen S; Bowtell DD; Odunsi K; Menon U; Morrison C; Lele S; Bshara W; Sucheston L; Beckmann MW; Hein A; Thiel FC; Hartmann A; Wachter DL; Anglesio MS; Høgdall E; Jensen A; Høgdall C; Kalli KR; Fridley BL; Keeney GL; Fogarty ZC; Vierkant RA; Liu S; Cho S; Nelson G; Ghatage P; Gentry-Maharaj A; Gayther SA; Benjamin E; Widschwendter M; Intermaggio MP; Rosen B; Bernardini MQ; Mackay H; Oza A; Shaw P; Jimenez-Linan M; Driver KE; Alsop J; Mack M; Koziak JM; Steed H; Ewanowich C; DeFazio A; Chenevix-Trench G; Fereday S; Gao B; Johnatty SE; George J; Galletta L; ; Goode EL; Kjær SK; Huntsman DG; Fasching PA; Moysich KB; Brenton JD; Kelemen LE
Br J Cancer; 2014 Dec; 111(12):2297-307. PubMed ID: 25349970
[TBL] [Abstract][Full Text] [Related]
3. High Expression of Folate Receptor Alpha (FOLR1) is Associated With Aggressive Tumor Behavior, Poor Response to Chemoradiotherapy, and Worse Survival in Rectal Cancer.
Chen CI; Li WS; Chen HP; Liu KW; Tsai CJ; Hung WJ; Yang CC
Technol Cancer Res Treat; 2022; 21():15330338221141795. PubMed ID: 36426547
[No Abstract] [Full Text] [Related]
4. Folate Receptor Alpha Expression Is Associated With Increased Risk of Recurrence in Triple-negative Breast Cancer.
Ginter PS; McIntire PJ; Cui X; Irshaid L; Liu Y; Chen Z; Shin SJ
Clin Breast Cancer; 2017 Nov; 17(7):544-549. PubMed ID: 28410844
[TBL] [Abstract][Full Text] [Related]
5. Folate receptor-α (FOLR1) expression and function in triple negative tumors.
Necela BM; Crozier JA; Andorfer CA; Lewis-Tuffin L; Kachergus JM; Geiger XJ; Kalari KR; Serie DJ; Sun Z; Moreno-Aspitia A; O'Shannessy DJ; Maltzman JD; McCullough AE; Pockaj BA; Cunliffe HE; Ballman KV; Thompson EA; Perez EA
PLoS One; 2015; 10(3):e0122209. PubMed ID: 25816016
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.
Notaro S; Reimer D; Fiegl H; Schmid G; Wiedemair A; Rössler J; Marth C; Zeimet AG
BMC Cancer; 2016 Aug; 16():589. PubMed ID: 27485273
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of folate receptor 1 in medulloblastoma and the correlation with clinicopathological characters and target therapeutic potential.
Liu H; Sun Q; Zhang M; Zhang Z; Fan X; Yuan H; Li C; Guo Y; Ning W; Sun Y; Song Y; Yu C
Oncotarget; 2017 Apr; 8(14):23048-23060. PubMed ID: 28416738
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles for folate receptor FOLR1 in signaling and cancer.
Nawaz FZ; Kipreos ET
Trends Endocrinol Metab; 2022 Mar; 33(3):159-174. PubMed ID: 35094917
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas.
Allard JE; Risinger JI; Morrison C; Young G; Rose GS; Fowler J; Berchuck A; Maxwell GL
Gynecol Oncol; 2007 Oct; 107(1):52-7. PubMed ID: 17582475
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of Cks1 in cancer: Evidence from a meta-analysis.
Zhang Y; Chen Y; You F; Li W; Lang Z; Zou Z
J Cell Physiol; 2019 Aug; 234(8):13423-13430. PubMed ID: 30605238
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA UCA1 as a novel biomarker of lymph node metastasis and prognosis in human cancer: a meta-analysis.
Liu C; Jin J; Shi J; Wang L; Gao Z; Guo T; He Y
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30918102
[No Abstract] [Full Text] [Related]
14. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
17. Expression status of folate receptor alpha is significantly correlated with prognosis in non-small-cell lung cancers.
Iwakiri S; Sonobe M; Nagai S; Hirata T; Wada H; Miyahara R
Ann Surg Oncol; 2008 Mar; 15(3):889-99. PubMed ID: 18181001
[TBL] [Abstract][Full Text] [Related]
18. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Expression of Folate Metabolism Enzymes and Its Diagnosis and Survival Prediction in Ovarian Carcinoma.
Chen J; Li L
Anal Cell Pathol (Amst); 2019; 2019():1438628. PubMed ID: 31049278
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
